Extramedullary multiple myeloma (EMD) is associated with low response rates, short progression-free survival, and poor prognosis. CAR T cells and bispecific antibodies (bsABs) have shown efficacy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results